Johnson & Johnson vaccine paused over rare blood clots
The US, South Africa and European Union have said they are temporarily halting the rollout of the Johnson & Johnson (J&J...
You are offline
US health authorities are calling for a pause in the use of the Johnson & Johnson Covid-19 vaccine, after reports of extremely rare blood clotting cases.
The Food and Drug Administration (FDA) said it was acting "out of an abundance of caution".
It said six cases of severe blood clotting had been detected in more than 6.8 million doses of the vaccine.
The recommendation follows similar rare cases in the AstraZeneca vaccine, which has prompted some curbs in its use.
View SourceRelated Notices
World Health Organization grants emergency use authorization to Johnson & Johnson vaccine
The World Health Organization on Friday granted emergency use authorization to the COVID-19 vaccine developed by Johnson...
Uganda declares Ebola outbreak after finding rare Sudan strain.
A flare-up of Ebola has been proclaimed in Uganda after health authorities affirmed a case of the generally uncommon Sud...
This notice has been removed
The content is no longer available
Covid-19: US agencies call for pause in Johnson & Johnson vaccine
US health authorities are calling for a pause in the use of the Johnson & Johnson Covid-19 vaccine, after reports of extremely rare blood clotting cases.
The Food and Drug Administration (FDA) said it was acting "out of an abundance of caution".
It said six cases of severe blood clotting had been detected in more than 6.8 million doses of the vaccine.
The recommendation follows similar rare cases in the AstraZeneca vaccine, which has prompted some curbs in its use.
Recent Searches
Recent Noticeboards
Trending
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Discussion (0)
No comments yet